Paracetamol

Global Analgesics Market Report 2023: Sector is Expected to Reach $67.4 Billion by 2028 at a CAGR of 4.49% - ResearchAndMarkets.com

Retrieved on: 
星期一, 四月 24, 2023

Analgesics are used for treating pain resulting from physiological injuries, surgeries, phantom aches, inflammation, neuropathic conditions and cancer treatments.

Key Points: 
  • Analgesics are used for treating pain resulting from physiological injuries, surgeries, phantom aches, inflammation, neuropathic conditions and cancer treatments.
  • However, by 2050, these numbers are expected to reach 2100 million, accounting for around 21% of the total global population.
  • The publisher provides an analysis of the key trends in each sub-segment of the global analgesics market report, along with forecasts at the global and regional level from 2023-2028.
  • Our report has categorized the market based on type, drug class, route of administration, pain type and application.

Watch out for dangerous combinations of over-the-counter cold medicine and prescription drugs – two pharmacoepidemiology experts explain the risks

Retrieved on: 
星期五, 四月 21, 2023

When colds, flus and allergies hit, many people automatically turn to over-the-counter medications to push through and treat their symptoms.

Key Points: 
  • When colds, flus and allergies hit, many people automatically turn to over-the-counter medications to push through and treat their symptoms.
  • Nearly 70% of adults in the U.S. use over-the-counter medications as a first-line response for treating cold and flu symptoms.
  • We are a pharmacoepidemiologist and pharmacist team and we investigate adherence to medications and potential harms of medications associated with drug-drug interactions.
  • Another study estimated that every year, 26,735 people went to the emergency room for adverse events related to over-the-counter cold and cough medications.

The dangers of mixing medications

    • Pharmacists and physicians are typically knowledgeable about potential drug interactions, so it is very important for patients to ask their health care providers which over-the-counter medications are safe for them to use.
    • It is important to read the package ingredients of over-the-counter medications closely to avoid duplication of doses.
    • Cold medications are typically made up of multiple ingredients, including pain relievers, nasal decongestants and cough suppressants or expectorants.
    • Combining these decongestants with monoaminooxidase inhibitors or tricyclic antidepressants could lead to very high blood pressure and heart rhythm problems.

Each person responds to drugs differently

    • As we age, our bodies begin to lose the ability to efficiently clear drugs, which increases the risk of adverse events and unintentional overdoses.
    • Some drugs can be dangerous for people who have particular health conditions.
    • In addition, since these drugs are associated with increased blood pressure, patients with hypertension, hyperthyroidism or heart disease should be careful when using them, or avoid them altogether.

Alternatives for children

    • The Food and Drug Administration and the Centers for Disease Control and Prevention do not recommend giving cold medications to children under age 4.
    • Because of a variety of factors, young children have a higher risk of accidental overdose and adverse events that could lead to death.
    • Research has shown that honey can be helpful for reducing cold and flu symptoms in children older than age 1.

Pregnancy best practices

    • Acetaminophen is the doctor-recommended over-the-counter medication for management of pain and fever at any stage of pregnancy.
    • Any other pain relievers or anti-inflammatory medicine such as ibuprofen, ketoprofen, naproxen and aspirin should not be taken during pregnancy without a doctor’s approval.
    • For symptoms such as nasal congestion during pregnancy, a decongestant called oxymetazoline in its intranasal form is the drug of choice.

Genexa Receives Its First Patent for Agave-Based Medicines

Retrieved on: 
星期二, 四月 18, 2023

Genexa, the first and only clean over-the-counter (OTC) medicine company making medicines for the entire family, announced today that the company has been granted a patent for its drinkable agave-based medicines containing acetaminophen, applicable to its best-selling Infants’ Pain & Fever and Kids’ Pain & Fever products.

Key Points: 
  • Genexa, the first and only clean over-the-counter (OTC) medicine company making medicines for the entire family, announced today that the company has been granted a patent for its drinkable agave-based medicines containing acetaminophen, applicable to its best-selling Infants’ Pain & Fever and Kids’ Pain & Fever products.
  • Artificial fillers typically comprise more than half of what is ingested each time traditional medicines are used.
  • “We are excited by the acceptance of our first patent and this milestone for a new category—clean medicine,” said Genexa Co-Founder and President, Max Spielberg.
  • As a Certified B-Corporation, Genexa is committed to using business as a force for good, meeting rigorous standards of social and environmental performance, accountability, and transparency.

Joy Organics Wins 2023 Award for the Best CBD Gummies Product on the Market

Retrieved on: 
星期二, 四月 4, 2023

NEW YORK, April 4, 2023 /PRNewswire/ -- CBD gummies produced by Joy Organics have won the 2023 Award for the Best CBD Gummies Product on the Market, Optimal Health News announced today. 

Key Points: 
  • Optimal Health News has named Joy Organics, a manufacturer of premium-quality CBD products, its pick for the best CBD gummies available on the market for 2023.
  • NEW YORK, April 4, 2023 /PRNewswire/ -- CBD gummies produced by Joy Organics have won the 2023 Award for the Best CBD Gummies Product on the Market, Optimal Health News announced today.
  • The global CBD gummies market size was valued at USD 1.6 billion in 2020 and has been expanding at a compound annual growth rate (CAGR) of 30.7%.
  • Alternatively, CBD products can help in reducing chronic pain by improving endocannabinoid receptor activity, decreasing inflammation, and acting in conjunction with neurotransmitters.

NCPDP's Lee Ann Stember Awarded APhA Honorary Membership at APhA Annual Meeting

Retrieved on: 
星期一, 三月 27, 2023

SCOTTSDALE, Ariz., March 27, 2023 /PRNewswire-PRWeb/ -- NCPDP announced its President & CEO Lee Ann Stember was awarded APhA Honorary Membership at the APhA Annual Meeting & Exposition on Saturday, March 25. As the 2023 award recipient, Stember joins a distinguished list of individuals including scholars, scientists, government officials, dignitaries, and luminaries from across the world who have received the prestigious award since it was first presented in 1856. The award recipient is selected by the APhA Board of Trustees. Nominees must have documented activity that has significantly impacted public health or has created or supported the expanding role of pharmacists, the profession, or the Association.

Key Points: 
  • SCOTTSDALE, Ariz., March 27, 2023 /PRNewswire-PRWeb/ -- NCPDP announced its President & CEO Lee Ann Stember was awarded APhA Honorary Membership at the APhA Annual Meeting & Exposition on Saturday, March 25.
  • In accepting the award Stember thanked the APhA Board and those who nominated her for the award.
  • Stember stated, "We believe the frontline provider role that [pharmacists] played in the pandemic will forever change the profession.
  • Journalists: Click here to download a photo of Lee Ann Stember.

CPSC Report Finds 37 Percent Spike in Child Poisoning Deaths in 2021

Retrieved on: 
星期一, 三月 20, 2023

WASHINGTON, March 20, 2023 /PRNewswire/ -- Unintentional pediatric poisoning deaths spiked 37 percent in 2021, with 59 children under five years old losing their lives after gaining access to prescribed or illicit drugs.

Key Points: 
  • WASHINGTON, March 20, 2023 /PRNewswire/ -- Unintentional pediatric poisoning deaths spiked 37 percent in 2021, with 59 children under five years old losing their lives after gaining access to prescribed or illicit drugs.
  • Child poisoning deaths have fallen by 73 percent since 1972 due to tough federal laws including the Poison Prevention Packaging Act (PPPA) of 1970 and the Child Nicotine Poisoning Prevention Act of 2015 and the cooperation of the poison prevention community.
  • This community includes the American Association of Poison Control Centers, standard development organizations, consumer advocates, medical professionals, industry and government.
  • CPSC's latest report notes that African American children suffer a higher rate of unintentional pediatric poisoning injuries, 21.4 percent, compared to being 15.8 percent of the U.S. population.

Milla Pharmaceuticals Inc. and the Alter Pharma Group Announce Launch of a Generic Version of Magnesium Sulfate in Water for Injection, in Non-PVC, Single-Patient Use Containers by Their Partner Athenex Pharmaceutical Division (APD)

Retrieved on: 
星期一, 三月 20, 2023

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230320005186/en/
    Alter Pharma #MakingAffordableMedicinesAvailableToAll Every day we ensure equal access to medicines and continuity of treatment for patients.
  • (Graphic: Business Wire)
    Magnesium Sulfate Injection is indicated for the prevention and control of seizures in preeclampsia and eclampsia.
  • This latest launch of Magnesium Sulfate Injection will help reduce the recent supply issues for the product experienced in the U.S.
  • This achievement marks the second ANDA commercialization for Milla Pharmaceuticals Inc. and the third for an Alter Pharma Group product in the U.S. market.

HSS Presents Research at 2023 AAOS Annual Meeting

Retrieved on: 
星期四, 三月 9, 2023

The average daily morphine usage after 48 hours for those who received the IV acetaminophen regimen was also significantly lower.

Key Points: 
  • The average daily morphine usage after 48 hours for those who received the IV acetaminophen regimen was also significantly lower.
  • The research suggests that IV acetaminophen is a safe and effective supplement to opioid-based pain management after surgery, and that it provides a promising option for pain control.
  • A study led by HSS research fellow Junho Song sought to identify predictors of patients who are not likely to improve.
  • The study included 448 patients who underwent minimally invasive transforaminal interbody fusion, laminectomy, or microdiscectomy at HSS between 2017 and 2021.

Perrigo Announces FDA Approval of the Store Brand OTC Equivalent of Advil® Dual Action Tablets

Retrieved on: 
星期三, 三月 1, 2023

DUBLIN, March 1, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it has received final approval from the U.S. Food and Drug Administration ("FDA") for its Abbreviated New Drug Application ("ANDA") for Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg, the store brand over-the-counter ("OTC") equivalent of Advil® Dual Action Tablets 250 mg/125 mg.

Key Points: 
  • DUBLIN, March 1, 2023 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it has received final approval from the U.S. Food and Drug Administration ("FDA") for its Abbreviated New Drug Application ("ANDA") for Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg, the store brand over-the-counter ("OTC") equivalent of Advil® Dual Action Tablets 250 mg/125 mg.
  • This approval was received on the first day possible following the expiration of the marketing exclusivity for Advil® Dual Action Tablets 250 mg/125 mg."
    Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg provides relief for multiple pain related symptoms by combining two ingredients indicated for OTC pain relief.
  • Retail sales for the national brand equivalent product for the last twelve months ending January 29, 2023, were approximately $69 million based on IRI multi-outlet market data.
  • Important safety information about Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg
    Before using the product, consumers should read the Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg drug facts label.

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2022 FINANCIAL RESULTS

Retrieved on: 
星期二, 二月 28, 2023

NASHVILLE, Tenn., Feb. 28, 2023 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceuticals company, announced today that it will release its annual 2022 financial results and provide a company update after the market closes on Tuesday, March 7, 2023.

Key Points: 
  • NASHVILLE, Tenn., Feb. 28, 2023 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceuticals company, announced today that it will release its annual 2022 financial results and provide a company update after the market closes on Tuesday, March 7, 2023.
  • A conference call will be held March 7 at 4:30 p.m. Eastern Time to discuss the results.
  • Once registered, participants can dial in from their phone using a dial-in and PIN number that will be provided to them.
  • Cumberland Pharmaceuticals is the largest biopharmaceutical company founded and headquartered in the Mid-South and is focused on the delivery of high-quality, prescription brands designed to improve patient care.